CLX

CLOROX CO

Consumer Defensive | Large Cap

$1.52

EPS Forecast

$1,674

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-20

Clorox Q3 FY2026: Adjusted EPS Rises on Efficiency as Purell Integration Begins, Margin Headwinds Remain

In its third-quarter report for fiscal year 2026, Clorox Company (ticker: CLX) delivered a portrait of efficiency meeting inflationary strain. The company posted net sales of $1.67 billion, with GAAP diluted earnings per share (EPS) of $1.54 and adjusted EPS of $1.64. While the headline EPS rose, gross margin faded by 140 basis points to 43.2%, underscoring ongoing cost pressures even as management cites cost savings and productivity gains. The release also flags the ongoing integration of Purell into the portfolio and progress on strategic moves like the GOJO Industries acquisition, alongside one-time items such as a Glad JV termination payment. For readers tracking EPS, earnings surprise potential, and revenue forecast implications, this quarter offers a nuanced read: solid adjusted profitability timing against a backdrop of margin headwinds and disciplined cash management.

Key Metrics and Takeaways

  • Ticker CLX reported third-quarter net sales of $1.67 billion, essentially flat versus the year-ago quarter.
  • EPS snapshot: Diluted EPS rose 3% to $1.54 from $1.50; Adjusted EPS rose 13% to $1.64 from $1.45.
  • Gross margin declined 140 basis points, to 43.2% from 44.6%, driven by higher manufacturing and logistics costs and less favorable mix, partially offset by cost savings.
  • Cash flow from operations year-to-date was $282 million, down 59% from $687 million in the prior year, largely due to a termination payment related to the Glad JV.
  • Strategic actions include advancing the Purell integration and accounting for the GOJO Industries acquisition within the portfolio, alongside ongoing productivity initiatives and investment in the company’s digital capabilities.
  • Non-GAAP disclosures accompany the results, with management noting that certain non-GAAP financial measures are referenced at the end of the release for reconciliations to GAAP metrics.

Analysis: What It Means for CLX and the Sector

The headline numbers read like a carefully managed performance rather than a dramatic swing. The EPS improvement on an adjusted basis reflects a portfolio that’s benefiting from cost savings and productivity initiatives, even as gross margin softness suggests ongoing inflationary pressures in manufacturing and logistics. In other words, the company is squeezing more operating leverage out of what appears to be a tougher cost environment, but the top-line remains a battleground where mix and input costs can bite margins.

The absence of a formal, public revenue forecast revision in this excerpt leaves analysts to triangulate sentiment from commentary about ongoing investments and the expected contribution of the Purell integration. The EPS consensus context isn’t explicit in the release, so readers should watch for how consensus expectations align with the adjusted EPS trajectory and gross margin trajectory as management provides more color in subsequent communications or investor presentations.

The strategic moves around Purell and the GOJO acquisition signal a pivot toward stronger premium-brand or hand-hygiene-category presence, which could help offset some consumer-goods cyclicality. Management’s emphasis on expanding the innovation pipeline and integrating Purell into the portfolio hints at a longer runway for growth beyond a traditional household-cleaning core. The one-time cash outflow from the Glad JV termination remains a reminder that certain strategic bets come with near-term cash-out consequences, even as they may unlock longer-term efficiency or growth benefits.

For sector peers, margin discipline will be the common throughline this year: input costs remain a pressure point, while cost-reduction programs and portfolio optimization could differentiate players with lean operations and faster go-to-market execution. The isn’t-a-miracle, isn’t-a-meltdown tone of CLX’s print could portend a broader narrative where earnings quality is increasingly defined by how well teams convert cost savings into durable profit growth, not just revenue growth.

Operational Highlights and Forward Look

Management highlights ongoing strategic and operational highlights, including the progress of Purell’s integration, which remains a central growth vector alongside the existing portfolio. The consolidated focus on productivity and digital investments aims to improve cost-to-serve dynamics and support more effective marketing and customer engagement. The non-GAAP disclosures emphasize that some metrics are intended to supplement, not replace, GAAP results, offering a more apples-to-apples view of underlying performance amid one-time effects like the Glad JV termination payment.

Looking ahead, the company positions itself to capitalize on efficiency gains while leaning into core brand strengths and new acquisitions. If the cost-savings trajectory continues and supply-chain dynamics stabilize, the path to a healthier gross margin may reassert itself, potentially lifting EPS beyond the favorable quarter-over-quarter trend. For investors and peers, the key questions will be: how durable are the cost savings, how quickly does Purell contribute to organic growth, and can the portfolio changes sustain margin resilience in a volatile input-cost environment?

Implications for Peers and Market Nointers

In a consumer staples landscape where inflation and logistics costs are persistent, CLX’s quarterly narrative underscores a broader theme: disciplined mix management and ongoing productivity gains can buoy EPS even when gross margin is pressured. Sector peers may respond by accelerating cost-savings initiatives, refining portfolio allocations toward higher-margin or higher-growth adjacencies, and communicating clearly about forward-looking revenue trends to manage earnings surprise risk expectations.

The ongoing integration of large acquisitions, paired with one-time cash outlays, will be a live test for the durability of earnings quality. If CLX delivers on the promise of Purell’s integration while maintaining margins, it could set a constructive benchmark for peers navigating similar portfolio expansions in hygiene and personal-care categories.

Bottom Line

Clorox’s Q3 FY2026 results offer a nuanced snapshot: adjusted profitability is improving through internal efficiencies and strategic portfolio moves, while margin pressure persists in the near term. The company’s emphasis on cost savings, the Purell integration, and the GOJO acquisition positioning suggest a multi-year strategy aimed at sustainable EPS growth, even as quarterly gross margins remain volatile. For investors tracking CLX, the key watchpoints are the durability of the cost-savings program, the pace of Purell’s contribution, and how management guides the revenue trajectory in the face of ongoing input-cost headwinds.

In the broader market, this quarter nudges the notion that EPS quality and margin discipline matter as much as headline sales, a reminder that earnings surprises—when they occur—are increasingly driven by the quality of the under-the-hood levers management pulls rather than a single standout category win.

Note: This summary reflects the disclosed figures and management commentary from the CLX third-quarter fiscal year 2026 press release. Non-GAAP measures are referenced in the release with reconciliations provided.